Skip to main content
Fig. 2 | BMC Public Health

Fig. 2

From: Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications

Fig. 2

Description of HR-HPV genotype prevalence at baseline (a) and at follow-up (24 months after baseline) (b). Data corresponding to the anal site are on the left and data corresponding to the oral site are on the right: the prevalence is expressed as proportion respect to the number of subjects with HPV testing available (165 anal samples at baseline and at follow-up, 106 oral samples at baseline and 162 oral samples at follow-up). HR-HPV: high risk HPV genotypes. HPV: human papilloma virus

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us